Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.89 +0.06 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Capital Expenditures (2020 - 2025)

Updated

Cullinan Therapeutics' Capital Expenditures was $11,000 in Q4 2025.

Analysis

Cullinan Therapeutics (CGEM) Capital Expenditures (2020 - 2025) Analysis & Trends

For FY2025, Capital Expenditures at Cullinan Therapeutics came in at $49,000.

  • Capital Expenditures shows a five-year compound annual growth rate of 37.4% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $208,000 in FY2023 (-81.6%) and $1.13 million in FY2022.
  • The Q4 2025 figure marks the highest quarterly Capital Expenditures since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Cullinan Therapeutics 919.35 Mn 584.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 159,000.00
Dec 31, 2022 882,000.00
Sep 30, 2022 251,000.00
Dec 31, 2020 -1,000.00
Sep 30, 2020 4,000.00
Jun 30, 2020 4,000.00
Mar 31, 2020 3,000.00
API Access

Cullinan Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CGEM&period=max&api_key=YOUR_API_KEY